Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05777187 · ClinicalTrials.gov registry record · NA
Mitigation of Postoperative Delirium in High-Risk Patients
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Terminated
- Registry status
- NA
- Development phase
- 7,412
- Enrollment target
NCT05777187 is a NA study that was terminated before completion, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 7,412 participants.
The verdict
NCT05777187, a NA study, was terminated before completion, sponsored by Icahn School of Medicine at Mount Sinai.
- TERMINATED
- Registry status
- NA
- Development phase
- 7,412 participants
- Enrollment target
Study Summary
Among patients with cognitive impairment (CI) that undergo surgery, the risk for developing postoperative delirium (POD) is high (50%) and associated with further morbidity and mortality. Yet, 30-40% of POD cases are preventable with perioperative management. This randomized pragmatic clinical trial aims to assess incidence of POD in adult surgical patients with CI, as well as provider adherence to a set of 12 perioperative best practice recommendations for perioperative management. Electronic health record (EHR) data will be used to identify patients as high risk for developing POD and clinical decision support (CDS) prompts within the EHR will display best practices. Cases will be randomized to either the control group, usual care or the intervention which includes the high-risk alert and best practice prompts.
Interventions
- OTHER Clinical Decision Support
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,412 participants |
| Start Date | 2023-06-20 |
| Est. Completion | 2024-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05777187
The ClinicalTrials.gov registry entry for NCT05777187 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7,412 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Clinical Decision Support is the first listed.
NCT05777187 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05777187 about?
NCT05777187 is a clinical study titled "Mitigation of Postoperative Delirium in High-Risk Patients". Among patients with cognitive impairment (CI) that undergo surgery, the risk for developing postoperative delirium (POD) is high (50%) and associated with further morbidity and mortality. Yet, 30-40% of POD cases are preventable with perioperative management. This randomized pragmatic clinical trial...
What is the current status of trial NCT05777187?
This trial is currently terminated. It is a NA study. The enrollment target is 7,412 participants. The study started on 2023-06-20. Estimated completion is 2024-08-31.
What interventions are being tested in trial NCT05777187?
The interventions under investigation include: Clinical Decision Support (OTHER).
Who is sponsoring clinical trial NCT05777187?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.